CytoSorbents enacts 1-for-20 reverse stock split
CytoSorbents effected a 1-for-20 reverse stock split, keeping authorized shares unchanged and trading continuing on Nasdaq on a split-adjusted basis.
Rhea-AI Filing Summary
CytoSorbents Corporation (CTSO) implemented a 1-for-20 reverse stock split of its common stock, effective at 12:01 a.m. E.T. on September 8, 2026. As of September 3, 2026, there were 63,022,020 shares of common stock outstanding that became subject to this reclassification.
Every twenty previously issued and outstanding shares of common stock were automatically reclassified into one share, with no change to the $0.001 par value and no change to the total number of authorized shares. Fractional entitlements were rounded up to the nearest whole share, and outstanding options and warrants were proportionately adjusted in both share amount and exercise price. Trading continues on Nasdaq on a split-adjusted basis under CTSO, with a new CUSIP of 23283X305.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Reverse stock split ratio: 1-for-20
Shares outstanding prior to reverse split: 63,022,020 shares
Effective date: September 8, 2026
+3 more
6 metrics
Reverse stock split ratio
1-for-20
Every twenty shares of common stock reclassified into one share at the effective time
Shares outstanding prior to reverse split
63,022,020 shares
Common stock outstanding as of September 3, 2026, before the reverse stock split
Effective date
September 8, 2026
Date the certificate of amendment and reverse stock split became effective
Effective time
12:01 a.m. E.T.
Time on September 8, 2026 when the reverse stock split became effective
New CUSIP number
23283X305
CUSIP for CytoSorbents common stock following the reverse stock split
Par value per share
$0.001
Par value of CytoSorbents’ common stock, unchanged by the reverse split
Key Terms
reverse stock split, par value, Certificate of Amendment, exchange agent, +1 more
5 terms
reverse stock split financial
"announced that it would effect a one-for-twenty (1:20) reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
par value financial
"its common stock, par value $0.001 per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
Certificate of Amendment regulatory
"filed a certificate of amendment to amend the Company’s Second Amended"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
exchange agent financial
"Equiniti Trust Company, LLC, is acting as exchange agent for the Reverse"
An exchange agent is a third party appointed to handle the practical steps when securities are being swapped, such as during mergers, tender offers, or restructurings. Think of it as a trusted post office that collects old shares, verifies ownership, completes required paperwork and regulatory filings, and delivers the new shares or cash to investors; its efficiency and accuracy affect how quickly and safely investors receive the value they're owed.
book-entry form financial
"Shareholders who hold their shares in book-entry form or in “street name”"
A book-entry form is an electronic record showing ownership of securities instead of a paper certificate; think of it like a bank account ledger that notes who owns shares. It matters to investors because it makes buying, selling and transferring securities faster, safer and cheaper by reducing paperwork, loss or forgery risk, and enabling easier settlement through brokers or a central depository.
FAQ
What reverse stock split did CTSO implement on September 8, 2026?
CytoSorbents implemented a 1-for-20 reverse stock split of its common stock, effective at 12:01 a.m. E.T. on September 8, 2026. Every twenty shares outstanding immediately before that time were automatically reclassified into one share.
How does the CTSO reverse split affect options and warrants?
The reverse stock split caused a proportionate reduction in the number of shares of common stock issuable upon exercise of outstanding options and warrants, with a corresponding adjustment to the exercise price per share for each such option and warrant.
What happens to CTSO trading and CUSIP after the reverse split?
From September 8, 2026, CytoSorbents’ common stock continues trading on The Nasdaq Stock Market LLC on a split-adjusted basis. The new CUSIP number for the common stock is 23283X305.
AI-generated analysis. How Rhea-AI works. Not financial advice.
